Mercury Biopharmaceutical Corporation (6932.TWO)

TWD 13.3

(-2.56%)

Total Debt Summary of Mercury Biopharmaceutical Corporation

  • Mercury Biopharmaceutical Corporation's latest annual total debt in 2023 was 42.34 Million TWD , down -2.47% from previous year.
  • Mercury Biopharmaceutical Corporation's latest quarterly total debt in 2024 Q1 was 41.5 Million TWD , down -1.99% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported annual total debt of 43.42 Million TWD in 2022, up 2059.27% from previous year.
  • Mercury Biopharmaceutical Corporation reported annual total debt of 2.01 Million TWD in 2021, up 570.33% from previous year.
  • Mercury Biopharmaceutical Corporation reported quarterly total debt of 41.6 Million TWD for 2024 Q2, up 1.07% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported quarterly total debt of 41.66 Million TWD for 2023 Q3, down -2.85% from previous quarter.

Annual Total Debt Chart of Mercury Biopharmaceutical Corporation (2023 - 2019)

Historical Annual Total Debt of Mercury Biopharmaceutical Corporation (2023 - 2019)

Year Total Debt Total Debt Growth
2023 42.34 Million TWD -2.47%
2022 43.42 Million TWD 2059.27%
2021 2.01 Million TWD 570.33%
2020 300 Thousand TWD 100.0%
2019 150 Thousand TWD 0.0%

Peer Total Debt Comparison of Mercury Biopharmaceutical Corporation

Name Total Debt Total Debt Difference
Allied Biotech Corporation 796.6 Million TWD 94.684%
GeneFerm Biotechnology Co., Ltd. 152.07 Million TWD 72.153%
Easywell Biomedicals, Inc. 386.34 Million TWD 89.038%
TTY Biopharm Company Limited 1.91 Billion TWD 97.789%
Synmosa Biopharma Corporation 2.43 Billion TWD 98.264%
Orient EuroPharma Co., Ltd. 4.84 Billion TWD 99.125%
Center Laboratories, Inc. 5.62 Billion TWD 99.247%
Tien Liang BioTech Co., Ltd. 84.65 Million TWD 49.977%
Orient Pharma Co., Ltd. 716.92 Million TWD 94.093%
InnoPharmax Inc. 21.49 Million TWD -96.981%
Johnson Chemical Pharmaceutical Works Co., Ltd. 160.83 Million TWD 73.669%
Excelsior Biopharma Inc. 377.4 Million TWD 88.779%
DV Biomed Co., Ltd. 387.69 Million TWD 89.077%
Foresee Pharmaceuticals Co., Ltd. 228.25 Million TWD 81.447%
Handa Pharmaceuticals, Inc. 13.24 Million TWD -219.856%
UniPharma Co., Ltd. 277 Thousand TWD -15188.448%
Anxo Pharmaceutical Co., Ltd. 787.84 Million TWD 94.625%
Alar Pharmaceuticals Inc. 1.4 Million TWD -2905.607%
Winston Medical Supply Co., Ltd. 107.32 Million TWD 60.543%
Bioray Biotech Co., Ltd 69.79 Million TWD 39.321%
TSH Biopharm Corporation Limited 7.84 Million TWD -439.959%